Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
3015646 | Revista Española de Cardiología | 2006 | 4 Pages |
Abstract
In dilated cardiomyopathy, severe functional mitral regurgitation (MR) is associated with a poor prognosis. In 112 consecutive clinically stable patients with non-ischemic dilated cardiomyopathy, echocardiography identified 15 (14%) patients who had severe MR (age, 53 ± 12 years; 80% male; left ventricular ejection fraction, 26 ± 8%). Existing medical treatment with ACE inhibitors and betablockers was increased up to the maximum tolerated doses. At 6 months, MR decreased by at least one grade in 13 (87%) patients (P =.001), as did the effective regurgitant orifice area (from 0.41 [0.05] mm2 to 0.20 [0.15] mm2; P <.001) and the jet area (from 13.6 [2.1] cm2 to 7.4 [4.5] cm2; P <.001). These changes correlated with an increase in left ventricular ejection fraction (from 26 [8]% to 35 [10]%, P=.009; r=0.60, P=.01) and a decrease in enddiastolic volume (from 168 [46] mL to 142 [72] mL, P=.04; r=.0.59, P=.02). An improvement in New York Heart Association class was observed (from 2.7 [0.5] to 1.9 [0.7]; P<.001). The severity of functional MR decreased after medical treatment was maximized. The decrease correlated with improvements in left ventricular systolic function.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Domingo A. Pascual Figal, Gonzalo de la Morena Valenzuela, Josefa González Carrillo, Pilar Ansaldo Ruiz, Juan A. Ruipérez Abizanda, Mariano Valdés Chavarri,